Market News & Trends
ProImmune Collaborates With The University of Texas Medical Branch to Advance Infectious Disease Research
ProImmune, Ltd.recently announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop…
Symbiosis Expands Commercial Capabilities With Addition of New Stability Chamber
Symbiosis Pharmaceutical Services has expanded its Quality Control (QC) laboratory with the installation of a new 30°C stability chamber. This addition enables Symbiosis to replicate…
Vetter Strengthens its Global Clinical Manufacturing Network With Strategic Site Enhancements
Vetter recently announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its Vetter Development Service offering,…
Alzheon Advances Next-Gen Pipeline With First Patient Dosed in ALZ-507 Study
Alzheon, Inc. recently announced the dosing of the first cohort of human volunteer subjects in a Phase 1 single and multiple ascending dose clinical trial of…
Cereno Scientific Reports Robust Safety & Tolerability in Long‑Term CS1 Pulmonary Arterial Hypertension Study
Cereno Scientific provides additional context on the safety and tolerability data from up to 12 months of treatment from the Expanded Access Program (EAP) with…
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
ANI Pharmaceuticals, Inc. recently announced publication of the results from the NEW DAY clinical trial involving ILUVIEN (fluocinolone acetonide intravitreal implant), 0.19 mg (ILUVIEN) for…
FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib
FORE Biotherapeutics, a registration-stage company dedicated to developing targeted therapies to treat patients with cancer, today announced that the U.S. Food and Drug Administration (FDA)…
Adragos Pharma Finalizes the Acquisition of Commercial-Scale, Sterile Fill-Finish Manufacturing Site From Sanofi
Adragos Pharma recently announced it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The Maisons-Alfort site is one of…
Cyclerion Therapeutics & Korsana Biosciences Announce Merger Agreement
Cyclerion Therapeutics, Inc. and Korsana Biosciences, Inc. recently announced they have entered into a definitive merger agreement for an all-stock transaction. Upon completion of the…
Amprion Grows Global Footprint With Australian Partnership & Expanded Research Collaborations
Amprion recently announced a series of strategic milestones that underscore the company’s accelerating growth, expanding international footprint, and continued commitment to advancing earlier and more accurate…
Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility
Samsung Biologics recently announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in…
PRISM ALS: New Stem Cell Models Could Transform Research Into Treatments for MND/ALS
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current cell models used for testing treatments do…
Symeres & Ambagon Therapeutics Collaborate on Molecular Glue Research in Colorectal Cancer
Symeres has recently partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class of small molecules, known as molecular glues, for potential…
ImmuneOncia Therapeutics & Lonza Collaborate to Manufacture a PD-L1 Antibody Targeting Immuno-Oncology
ImmuneOncia Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on immuno-oncology, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced today…
Vetter Recognized as 2026 CDMO Leadership Awards Winner
Vetter receives recognition as CDMO of the year in the category “Finished Dose” of the 2026 CDMO Leadership Awards. The award honors the company for…
Thermo Fisher Scientific & SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions
Thermo Fisher Scientific Inc. recently announced a strategic collaboration with SHL Medical, a leading provider of advanced drug delivery systems, alongside an expansion of sterile…
Optibrium Introduces Graphical Interface for QuanSA to Enhance Ligand-Based Affinity Predictions
Optibrium recently announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of…
Quotient Therapeutics Announces Collaboration With Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year research collaboration agreement with Merck, known…
Karyopharm’s Phase 3 in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
Karyopharm Therapeutics Inc. recently reported topline results from its Phase 3 SENTRY trial, a randomized, double-blind, placebo-controlled trial of 60 mg selinexor in combination with…
ImmuneBridge Announces New Partnership Focus, Investment & CEO
ImmuneBridge recently announced it will make its platform available to partners – ranging from small biotech startups to established pharmaceutical companies. Therapeutic co-development partners will…
